The cholesterol dependence of activation and fast desensitization of the nicotinic acetylcholine receptor.
When nicotinic acetylcholine receptors are reconstituted into lipid bilayers lacking cholesterol, agonists no longer stimulate cation flux. The kinetics of this process are difficult to study because variations in vesicle morphology cause errors in flux measurements. We developed a new stopped-flow fluorescence assay to study activation independently of vesicle morphology. When receptors were rapidly mixed with agonist plus ethidium, the earliest fluorescence increase reported the fraction of channels that opened and their apparent rate of fast desensitization. These processes were absent when the receptor was reconstituted into dioleoylphosphatidylcholine or into a mixture of that lipid with dioleoylphosphatidic acid (12 mol%), even though a fluorescent agonist reported that resting-state receptors were still present. The agonist-induced channel opening probability increased with bilayer cholesterol, with a midpoint value of 9 +/- 1.7 mol% and a Hill coefficient of 1.9 +/- 0.69, reaching a plateau above 20-30 mol% cholesterol that was equal to the native value. On the other hand, the observed fast desensitization rate was comparable to that for native membranes from the lowest cholesterol concentration examined (5 mol%). Thus the ability to reach the open state after activation varies with the cholesterol concentration in the bilayer, whereas the rate of the open state to fast desensitized state transition is unaffected. The structural basis for this is unknown, but an interesting corollary is that the channels of newly synthesized receptors are not fully primed by cholesterol until they are inserted into the plasma membrane--a novel form of posttranslational processing.
Rankin
S E
SE
Department of Anesthesia, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.
Addona
G H
GH
Kloczewiak
M A
MA
Bugge
B
B
Miller
K W
KW
D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D002784:Cholesterol / Q000494:pharmacology*; D004996:Ethidium / Q000378:metabolism / Q000494:pharmacology; D005456:Fluorescent Dyes / Q000378:metabolism; D005470:Fluorometry; D007700:Kinetics; D008051:Lipid Bilayers / Q000737:chemistry; D008081:Liposomes / Q000378:metabolism; D018722:Nicotinic Agonists / Q000378:metabolism / Q000494:pharmacology; D010713:Phosphatidylcholines / Q000378:metabolism; D010743:Phospholipids / Q000737:chemistry / Q000378:metabolism; D011978:Receptors, Nicotinic / Q000737:chemistry / Q000378:metabolism*; D014101:Torpedo
D005456:Fluorescent Dyes; D008051:Lipid Bilayers; D008081:Liposomes; D018722:Nicotinic Agonists; D010713:Phosphatidylcholines; D010743:Phospholipids; D011978:Receptors, Nicotinic; D002217:Carbachol; D002784:Cholesterol; C017251:1,2-oleoylphosphatidylcholine; D004996:Ethidium